Literature DB >> 17146463

Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection.

M L Munier1, A D Kelleher.   

Abstract

Human immunodeficiency virus (HIV) infection causes chronic progressive immunodeficiency and immune dysregulaton. Although simple depletion of the major target of HIV infection, the CD4+ T cell, can explain much of the immunosuppression seen, there are multiple other factors contributing to the immune dysregulation. CD4+ T-cell depletion induces a range of homeostatic mechanisms that contribute to immune activation and cell turnover, providing a milieu conducive to further viral replication and cell destruction, resulting in functional defects in various lymphoid organs. These changes are progressive and in turn compromise the homeostatic processes. Further, the infection, like any other viral infection, provokes an active immune response consisting of both CD4+ and CD8+ T-cell responses. Both appear compromised, displaying aberrant memory cell production. While some of these defects result from viral variation and the chronicity of antigen presentation, other defects of memory cell production appear very early during the primary immune response limiting the viral specific T-cell responses from the outset. This, combined with the ability of the virus to escape any successful immune responses, results in an attenuated immune response that eventually becomes exhausted, characterized by progressive deficits in T-cell repertoire. Furthermore, negative regulatory mechanisms that normally control the immune response may be aberrantly invoked, perhaps directly by the virus, further compromising the efficacy of the immune response. Rational design of effective immunotherapies depends on a clear understanding of the processes compromising the immune response to HIV.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17146463     DOI: 10.1038/sj.icb.7100015

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  19 in total

1.  T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue.

Authors:  Samantha R Stubblefield Park; Mi Widness; Alan D Levine; Catherine E Patterson
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Biomarkers of HIV Immune Reconstitution Inflammatory Syndrome.

Authors:  Shuli Bonham; David B Meya; Paul R Bohjanen; David R Boulware
Journal:  Biomark Med       Date:  2008       Impact factor: 2.851

3.  Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy.

Authors:  Luc Kestens; Nabila Seddiki; Paul R Bohjanen
Journal:  Curr Opin HIV AIDS       Date:  2008-07       Impact factor: 4.283

4.  Responsiveness of HIV-specific CD4 T cells to PD-1 blockade.

Authors:  Filippos Porichis; Douglas S Kwon; Jennifer Zupkosky; Daniel P Tighe; Ashley McMullen; Mark A Brockman; David F Pavlik; Marta Rodriguez-Garcia; Florencia Pereyra; Gordon J Freeman; Daniel G Kavanagh; Daniel E Kaufmann
Journal:  Blood       Date:  2011-06-07       Impact factor: 22.113

5.  Increased level of arginase activity correlates with disease severity in HIV-seropositive patients.

Authors:  T E Cloke; L Garvey; B-S Choi; T Abebe; A Hailu; M Hancock; U Kadolsky; C R M Bangham; M Munder; I Müller; G P Taylor; P Kropf
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

6.  APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load.

Authors:  Kavidha Reddy; Cheryl A Winkler; Lise Werner; Koleka Mlisana; Salim S Abdool Karim; Thumbi Ndung'u
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

7.  Expression of interleukin-15 and interleukin-15Rα in monocytes of HIV type 1-infected patients with different courses of disease progression.

Authors:  Maciej Tarkowski; Laurenzia Ferraris; Sara Martone; Francesco Strambio de Castillia; Donatella Misciagna; Renata I Mazzucchelli; Emanuela Lattuada; Giuseppe Paraninfo; Massimo Galli; Agostino Riva
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-23       Impact factor: 2.205

Review 8.  Chronic innate immune activation as a cause of HIV-1 immunopathogenesis.

Authors:  Adriano Boasso; Gene M Shearer
Journal:  Clin Immunol       Date:  2007-10-03       Impact factor: 3.969

9.  Programmed death-1 is a marker for abnormal distribution of naive/memory T cell subsets in HIV-1 infection.

Authors:  Gaëlle Breton; Nicolas Chomont; Hiroshi Takata; Rémi Fromentin; Jeffrey Ahlers; Abdelali Filali-Mouhim; Catherine Riou; Mohamed-Rachid Boulassel; Jean-Pierre Routy; Bader Yassine-Diab; Rafick-Pierre Sékaly
Journal:  J Immunol       Date:  2013-08-05       Impact factor: 5.422

10.  XVII International AIDS Conference: From Evidence to Action - Basic science.

Authors:  David Gilden; Rodney Kort
Journal:  J Int AIDS Soc       Date:  2009-10-06       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.